Variable | Before surgery (n = 41) | After surgery (n = 41) | Percent change [95% CI] | p-value |
---|---|---|---|---|
BMI (kg/m2) | 45.8 ± 6.3 | 37.9 ± 7.6 | − 17.4 [(− 19.5) to (− 15.3)] | < 0.001 |
Glucose (mg/dl) | 116.7 ± 36.6 | 100 ± 15.8 | − 5.0 [(− 20.7) to (10.6)] | 0.009 |
Insulin (mIU/l) | 16.5 (12.3–13.2) | 9.75 (7.1–13.2) | − 27.3 [(− 50.6) to (− 4.0)] | < 0.001 |
HOMA2-IR | 2.5 (2.5–3.8) | 1.5 (1.2–2.2) | − 23.4 [(− 49.6) to (− 2.8)] | 0.002 |
NEFA (mmol/l) | 0.78 ± 0.34 | 0.74 ± 0.32 | 29.0 [(− 13.8) to (71.6)] | 0.67 |
ADIPO-IR | 81.2 (48.0–137.0) | 57.5 (25.5–94.1) | − 16.0 [(− 58.4) to (26.3)] | 0.009 |
Hb1Ac | 7.1 ± 1.8 | 5.9 ± 0.94 | − 15.1 [(− 19.8) to (− 10.4)] | < 0.001 |
Apo A-I (mg/dl) | 107.1 ± 22.3 | 129.8 ± 20.2 | 25.7 [(16.0) to (34.0)] | < 0.001 |
Male | 114.8 ± 25.3 | 128.7 ± 17.9 | 13.8 [(2.4) to (25.3)] | 0.04 |
Female | 105.2 ± 21.6 | 130.1 ± 21.0 | 27.7 [(16.8) to (38.5)] | < 0.001 |
Apo B (mg/dl) | 81.6 ± 19.4 | 101.7 ± 18.2 | 26.0 [(16.3) to (35.1)] | < 0.001 |
TC (mg/dl) | 176.3 ± 54.7 | 166 ± 29.8 | − 2.2 [(− 8.3) to (4.0)] | 0.18 |
HDL-C (mg/dl) | 42.4 ± 9.9 | 39.2 ± 6.1 | − 3.8 [(− 10.6) to (3.1)] | 0.044 |
Male | 40.5 ± 7.4 | 37.5 ± 7.0 | − 4.7 [(− 20.8) to (11.3)] | 0.40 |
Female | 43.0 ± 10.7 | 39.7 ± 5.8 | − 3.4 [(− 11.5) to (4.6)] | 0.08 |
LDL-C (mg/dl) | 102.9 ± 27 | 105.1 ± 21.3 | 10.2 [(− 5.6) to (26.0)] | 0.67 |
TG (mg/dl) | 141.4 ± 41.2 | 118.5 ± 43.4 | − 12.5 [(− 23.1) to (− 1.2)] | 0.003 |
VLDL-C (mg/dl) | 25.5 ± 10 | 22.4 ± 9.1 | 0.5 [(− 18.0) to (19.0)] | 0.09 |
CEC | 0.91 ± 0.13 | 1.02 ± 0.16 | 11.5 [(6.1) to (17.0)] | 0.00017 |
Adiponectin (µg/ml) | 5.6 ± 2.2 | 6.8 ± 2.5 | 32.2 [(15.0) to (49.4)] | 0.005 |
Log resistin | 2.3 ± 0.72 | 2.0 ± 0.80 | − 6.0 [(− 18.0) to (5.9)] | 0.07 |
Log MCP-1 | 1.8 ± 0.43 | 1.7 ± 0.50 | − 2.4 [(− 12.9) to (8.0)] | 0.17 |
IL-10 (pg/ml) | 0.25 (0.05–0.7) | 0.39 (0.14–0.56) | 47.8 [(68.0) to (879.2.0)] | 0.64 |
TNF-alpha (pg/ml) | 2.3 ± 1.8 | 2.4 ± 1.3 | 30.0 [(0.0) to (60.3)] | 0.83 |